세계의 4가 백신 시장 보고서(2023년)

“Quadrivalent Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quadrivalent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quadrivalent? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The quadrivalent market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Intradermal Shot; Intramuscular Injection; Nasal Spray

• 2) By Technology: Conjugated; Live; Inactivated; Recombinant; Toxoid; Other Technologies

• 3) By Disease: Cancer; Hepatitis; Pneumococcal disease; COVID-19; Influenza; Human Papilloma Virus; Meningococcal Disease; Polio; Rotavirus; Other Diseases

• 4) By Age Group: Pediatric; Adult

• 5) By Distribution Channel: Hospital And Pharmacy; Government Suppliers; Other Channels (NGOs)

• Companies Mentioned: AstraZeneca Plc.; Serum Institute of India Pvt. Ltd.; Sanofi S.A.; GlaxoSmithKline Plc.; CSL Limited

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the quadrivalent market are AstraZeneca Plc., Serum Institute of India Pvt. Ltd., Sanofi S.A., GlaxoSmithKline Plc., CSL Limited, Bharat Biotech International Ltd., Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson SA, Novartis AG, Pfizer Inc., Xenetic Biosciences Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., and Chongqing Zhifei Biological Products Co. Ltd.

The global quadrivalent market is expected to grow from $7.30 billion in 2022 to $7.87 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The quadrivalent market is expected to grow to $10.58 billion in 2027 at a CAGR of 7.7%.

The quadrivalent market consists of sales of afluria quadrivalent, fluarix quadrivalent, flublok quadrivalent, fluzone quadrivalent (influenza virus vaccine), flulaval quadrivalent, flucelvax quadrivalent, menactra and menveo. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Quadrivalent is a vaccination that stimulates the immune system to respond to distinct antigens, such as four different viruses or bacteria. A quadrivalent vaccination is intended to protect against four distinct flu viruses, two of which are type A and type B.

North America was the largest region in the quadrivalent market in 2022. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of quadrivalent are intradermal shots, intramuscular injections, and nasal sprays. An intradermal shot refers to the vaccine that is injected between the epidermis and hypodermis, often known as the top and bottom layers of the skin, according to the Center For Disease Control (CDC). It is prepared by various technologies including conjugated, live, inactivated, recombinant, toxoid, and others for immunization against cancer, hepatitis, pneumococcal disease, COVID-19, influenza, human papillomavirus, meningococcal disease, polio, rotavirus, and other diseases of pediatric and adult age groups. They are distributed through hospital and pharmacy, government suppliers, and other channels.

The rising prevalence of chronic and infectious diseases is expected to propel the growth of the quadrivalent market moving forward. A chronic disease is a long-term sickness caused by genetics and lifestyle, whereas an infectious disease is any ailment caused by an infectious agent such as a virus, bacteria, fungus, or protozoan. Quadrivalent vaccines have a significant impact in preventing morbidity and mortality from serious infections, as well as diseases other than the specific infections they are designed to target. Quadrivalent vaccines are being used to prevent chronic (non-communicable) diseases when infectious agents are involved in carcinogenesis. For instance, in September 2022, according to the World Health Organization, a Switzerland-based agency responsible for international public health, every year, 17 million people die from a chronic or noncommunicable disease (NCD) before the age of 70. Furthermore, in 2021, there were estimated 247 million cases of malaria (an infectious disease) globally, with an estimated 619,000 fatalities. Therefore, the rising prevalence of chronic and infectious diseases is driving the growth of the quadrivalent market.

Product innovations are a key trend gaining popularity in the quadrivalent market. Major companies operating in the quadrivalent market are focused on developing innovative solutions to strengthen their position in the market. For instance, in September 2022, AstraZeneca, a UK-based pharmaceutical company, launched FluMist quadrivalent (Influenza Vaccination Live, Intranasal), a Food and Drug Administration (FDA)-approved nasal-spray flu vaccine for persons aged 2 to 49, that can be administered through a needle-free nasal spray. It is a live attenuated influenza vaccine (LAIV), available in trivalent or quadrivalent formulations, and is covered by most health insurance plans as well as the vaccines for children program.

In June 2020, Merck & Co. Inc., a US-based pharmaceutical company completed the acquisition of Themis Bioscience Gmbh for an undisclosed amount. This acquisition focuses on accelerating the development of a measles vector-based SARS-CoV-2 vaccine candidate. Themis Bioscience GmbH is an Austria-based start-up biotechnology company that develops vaccines to prevent infectious diseases.

The countries covered in the quadrivalent market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The quadrivalent market research report is one of a series of new reports from The Business Research Company that provides quadrivalent market statistics, including quadrivalent industry global market size, regional shares, competitors with a quadrivalent market share, detailed quadrivalent market segments, market trends and opportunities, and any further data you may need to thrive in the quadrivalent industry. This quadrivalent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Quadrivalent Market Characteristics

3. Quadrivalent Market Trends And Strategies

4. Quadrivalent Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Quadrivalent Market
• 4.2. Ukraine-Russia War Impact On Quadrivalent Market
• 4.3. Impact Of High Inflation On Quadrivalent Market

5. Quadrivalent Market Size And Growth

• 5.1. Global Quadrivalent Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Quadrivalent Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Quadrivalent Market Segmentation

• 6.1. Global Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Intradermal Shot
• Intramuscular Injection
• Nasal Spray
• 6.2. Global Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Conjugated
• Live
• Inactivated
• Recombinant
• Toxoid
• Other Technologies
• 6.3. Global Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Cancer
• Hepatitis
• Pneumococcal Disease
• COVID-19
• Influenza
• Human Papilloma Virus
• Meningococcal Disease
• Polio
• Rotavirus
• Other Diseases
• 6.4. Global Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Pediatric
• Adult
• 6.5. Global Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospital And Pharmacy
• Government Suppliers
• Other Channels

7. Quadrivalent Market Regional And Country Analysis

• 7.1. Global Quadrivalent Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Quadrivalent Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Quadrivalent Market

• 8.1. Asia-Pacific Quadrivalent Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Quadrivalent Market

• 9.1. China Quadrivalent Market Overview
• 9.2. China Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Quadrivalent Market

• 10.1. India Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Quadrivalent Market

• 11.1. Japan Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Quadrivalent Market

• 12.1. Australia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Quadrivalent Market

• 13.1. Indonesia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Quadrivalent Market

• 14.1. South Korea Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Quadrivalent Market

• 15.1. Western Europe Quadrivalent Market Overview
• 15.2. Western Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Quadrivalent Market

• 16.1. UK Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Quadrivalent Market

• 17.1. Germany Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Quadrivalent Market

• 18.1. France Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Quadrivalent Market

• 19.1. Eastern Europe Quadrivalent Market Overview
• 19.2. Eastern Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Quadrivalent Market

• 20.1. Russia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Quadrivalent Market

• 21.1. North America Quadrivalent Market Overview
• 21.2. North America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Quadrivalent Market

• 22.1. USA Quadrivalent Market Overview
• 22.2. USA Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Quadrivalent Market

• 23.1. South America Quadrivalent Market Overview
• 23.2. South America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Quadrivalent Market

• 24.1. Brazil Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Quadrivalent Market

• 25.1. Middle East Quadrivalent Market Overview
• 25.2. Middle East Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Quadrivalent Market

• 26.1. Africa Quadrivalent Market Overview
• 26.2. Africa Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Quadrivalent Market Competitive Landscape And Company Profiles

• 27.1. Quadrivalent Market Competitive Landscape
• 27.2. Quadrivalent Market Company Profiles
  • 27.2.1. AstraZeneca Plc.
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Serum Institute of India Pvt. Ltd.
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Sanofi S.A.
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. GlaxoSmithKline Plc.
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. CSL Limited
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Quadrivalent Market

29. Quadrivalent Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer